Many low-income and moderate-income U.S. adults say they would be willing to pay about $18 extra per month for generous coverage for specialty drugs.
A team of researchers backed by Bristol-Myers Squibb Company, New York (NYSE:BMY) -- a pharmaceutical company -- has presented that finding in a survey report published in the latest issue of Health Affairs, a peer-reviewed academic journal that focuses on health care finance and health care organization.
Originally published on LifeHealthPro. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.